Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines
eLife, 2024. Sujeethkumar Prithiviraj, Alejandro Garcia Garcia, Karin Linderfalk, Bai Yiguang, Sonia Ferveur, Ludvig Nilsén Falck, Agatheeswaran Subramaniam, Sofie Mohlin, David Hidalgo, Steven J Dupard, Deepak Bushan Raina, Paul E Bourgine Abstract Tissue engineering strategies predominantly rely on the production of living substitutes,
Comments